Back

The trials-and-errors of antiarrhythmic drug therapy

19 March 2019 (11:00 - 11:18)
Organised by:
Congress Presentation Part of: Critical appraisal of antiarrhythmic drug therapy - The science behind trial-and-error Arrhythmias EHRA Premium Access EHRA 2019

About the speaker

Photo
Professor John Camm

City St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Genetic basis for tailored drug therapy for ventricular arrhythmias
Associate Professor C. Remme (Amsterdam, NL)
Presentation thumbnail
Rationale behind development of novel drugs for atrial arrhythmias
Professor J. Heijman (Graz, AT)
Slides Video
Presentation thumbnail
Antiarrhythmic drugs - What, why, when to whom
Professor G. Dan (Bucharest, RO)
Presentation thumbnail
Panel discussion
Video

Access the full session

Session thumbnail
Critical appraisal of antiarrhythmic drug therapy - The science behind trial-and-error

The Event

Event poster

EHRA 2019

19 March 2019 11:00 CET
You may be interested in
thumbnail
Congress Session
EHRA Consensus Paper on Antiarrhythmic Drugs (AADs)
30 March 2025
thumbnail
Congress Presentation
Atrioventricular conduction disorders associated to betablocker treatment in patients with heart failure
20 May 2023
thumbnail
Congress Presentation
Efficacy and limitations of quinidine therapy in patients with Brugada Syndrome
3 September 2019
thumbnail
Congress Presentation
Ventricular premature contractions coupling interval behavior and efficacy of anti-arrhythmic drugs
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources